...
首页> 外文期刊>Journal of Clinical Microbiology >In vitro evaluation of pyridine-2-azo-p-dimethylaniline cephalosporin, a new diagnostic chromogenic reagent, and comparison with nitrocefin, cephacetrile, and other beta-lactam compounds.
【24h】

In vitro evaluation of pyridine-2-azo-p-dimethylaniline cephalosporin, a new diagnostic chromogenic reagent, and comparison with nitrocefin, cephacetrile, and other beta-lactam compounds.

机译:吡啶-2-偶氮-对二甲基苯胺头孢菌素(一种新的生色试剂)的体外评估,并与硝基cefin,头孢乙腈和其他β-内酰胺化合物进行比较。

获取原文
           

摘要

Pyridine-2-azo-p-dimethylanaline cephalosporin (PADAC), a chromogenic reagent which is purple and changes to yellow upon cleavage of its beta-lactam ring, was evaluated in comparison with other chromogenic cephalosporins. PADAC exhibited little antimicrobial activity against gram-negative bacteria, but did have good activity (minimum inhibitory concentration, 0.12 to 0.5 microgram/ml) against Staphylococcus aureus, a quality comparable to nitrocefin. Nitrocefin, however, demonstrated an unexpected and uniquely potent activity against Streptococcus faecalis (minimum inhibitory concentration, less than or equal to 0.06 to 0.12 microgram/ml) The relative hydrolysis rate of PADAC when subjected to six different beta-lactamases was substantially greater than that of cephacetrile, but less than that of nitrocefin. The relative hydrolysis rates of PADAC and nitrocefin were comparable with type IIIa beta lactamase and the derived from Bacillus cereus. The inhibition of beta-lactamase hydrolysis of the chromogenic cephalosporin substrates by six enzyme-stable inhibitors was generally greater with PADAC than with nitrocefin. Unlike nitrocefin, PADAC mixed with 50% human serum or various broth culture media showed no evidence of color change or degradation over several hours. The subsequent enzyme hydrolysis rates of such mixtures were the same as in phosphate buffer. Beta-lactamase-containing bacterial suspensions and clinical specimens containing such bacteria produced positive visual and spectrophotometric color changes when mixed with PADAC or nitrocefin. Although color changes occurred more slowly with PADAC than with nitrocefin, PADAC was not adversely influenced (non-enzyme-related color change) by the protein content of specimens. PADAC appears to be a promising alternative for beta-lactamase diagnostic testing in the clinical and research microbiology laboratory.
机译:与其他生色头孢菌素比较,评估了吡啶-2-偶氮-对二甲基苯胺头孢菌素(PADAC),该发色剂为紫色,在其β-内酰胺环断裂时变为黄色。 PADAC对革兰氏阴性菌几乎没有抗菌活性,但对金黄色葡萄球菌确实具有良好的活性(最低抑菌浓度为0.12至0.5微克/ ml),其质量可与硝基cefin媲美。但是,硝基硝基芬对粪便链球菌具有出乎意料的独特活性(最低抑菌浓度,小于或等于0.06至0.12微克/毫升)经受六种不同的β-内酰胺酶时,PADAC的相对水解速率大大高于头孢乙腈的含量,但少于硝基cefin。 PADAC和nitrocefin的相对水解速率与IIIa型内酰胺酶和蜡状芽孢杆菌衍生的相当。六种酶稳定抑制剂对发色性头孢菌素底物的β-内酰胺酶水解的抑制作用一般用PADAC比用硝化芬芬更大。与硝化菌素不同,PADAC与50%的人血清或各种肉汤培养基混合后,在数小时内未显示出颜色变化或降解的迹象。此类混合物的后续酶水解速率与磷酸盐缓冲液中的相同。当与PADAC或硝化甘油混合使用时,含β-内酰胺酶的细菌悬浮液和含有此类细菌的临床标本会产生积极的视觉和分光光度颜色变化。尽管PADAC的颜色变化发生的速度比硝菌素的变化慢,但是PADAC不受样品蛋白质含量的不利影响(与酶无关的颜色变化)。 PADAC似乎是临床和研究微生物实验室中β-内酰胺酶诊断测试的有希望的替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号